Invention Grant
- Patent Title: Polynucleotides encoding interleukin-12 (IL12) and uses thereof
-
Application No.: US16842300Application Date: 2020-04-07
-
Publication No.: US11000573B2Publication Date: 2021-05-11
- Inventor: Joshua Frederick , Susannah Hewitt , Ailin Bai , Stephen Hoge , Vladimir Presnyak , Iain McFadyen , Kerry Benenato , Ellalahewage Sathyajith Kumarasinghe
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Amy E. Mandragouras, Esq.; Ariana D. Harris
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K38/20 ; A61K9/51 ; C07K14/54 ; A61K31/7088 ; A61K31/7115 ; C12N15/62 ; A61P35/00 ; A61K9/00

Abstract:
The present disclosure relates to polynucleotides comprising an open reading frame of linked nucleosides encoding human interleukin-12 (IL12), functional fragments thereof, and fusion proteins comprising IL12. In some embodiments, the open reading frame is sequence-optimized. In particular embodiments, the disclosure provides sequence-optimized polynucleotides comprising nucleotides encoding the polypeptide sequence of human IL12, or sequences having high sequence identity with those sequence optimized polynucleotides.
Public/Granted literature
- US20200376081A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF Public/Granted day:2020-12-03
Information query